Josiah Macy Jr. Foundation – Limited Submission
Macy Faculty Scholars

Internal Competition Deadline: August 12, 2024
Proposal Deadline: September 15, 2024, 11:59 p.m. ET

Funding:
Up to $100,000 salary support per year for two years for 50% protected time to pursue a mentored educational project at the home institution. $25,000 per year for two years to subsidize the cost of professional development activities and related project expenses.

Career Stage: Early Career

Purpose:
Macy Faculty Scholars Program aims to identify and nurture promising early-career educators in medicine and nursing. The program will help develop the next generation of national leaders in medical and nursing education by identifying outstanding educators, physicians, nurses and role models — individuals who represent the breadth of diversity seen in learners, patient populations and health care settings around the country. Each scholar is assigned one mentor from the National Advisory Committee and one peer mentor from the family of alumni scholars.

Eligibility:

Candidates should:

• Have approximately three to eight years of faculty experience at the time of application.
• Be a doctorally prepared faculty member in good standing at the sponsoring school.
• Be nominated by the dean of the nursing or medical school. There can be only one nominee per nursing or medical school.
• Have an educational scholarship project with the appropriate institutional support.
• Have a faculty mentor who will advise the candidate on their educational project and career development.
• Have an institutional commitment for the protection of 50% of the candidate’s time.
• Be a citizen or permanent resident of the United States or its territories.

---

Elsa U. Pardee Foundation

Deadline: August 31, 2024

Career Stage: Postdocs, early and established career

Funding:
By design, there are no limits set on the amount that can be requested. It must be reasonably supported by the scope of the project outlined in the application. Indirect costs cannot exceed 5% of the total amount requested.

Description:
The Elsa U. Pardee Foundation funds research to investigators in United States nonprofit institutions proposing research directed toward identifying new treatments or cures for cancer. The foundation funds projects for a one-year period that will allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding by the foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment or cure should be clearly identified. The foundation particularly welcomes innovative, small-scale, short-term projects that may be difficult to fund elsewhere until some interesting results are obtained.

Eligibility:
Post-docs who are on the tenure track and have a tenured mentor are eligible. Priority is given to researchers at nonprofit institutions in the United States who are new to the field of cancer research, or to established research investigators examining new approaches to cancer cure.

AHA Postdoctoral Fellowship

Deadline: Thursday, September 5, 2024

Purpose:
Enhances the training of postdoctoral applicants who are not yet independent. The applicant must be embedded in an appropriate investigative group with the mentorship, support, and relevant scientific guidance of a research mentor. Within this award, additional collaboration money has been designated through the AHA/CHF Congenital Heart Defect Research Awards and AHA/VIVA Physician Research Award and by the Barth Syndrome Foundation and California Walnut Commission.

---

March of Dimes

Deadline: September 6, 2024

Funding: $200,000 over two years inclusive of 10% indirect costs

Purpose:
Cardiovascular health conditions developed during pregnancy or exacerbated during pregnancy: Proposed studies in this topic area should focus on cardiovascular conditions that begin, develop or worsen during pregnancy and identify tangible ways to characterize, prevent and/or mitigate their development.

Eligibility
Open to: health professionals, health researchers, epidemiologists and social scientists with doctoral academic degrees and either a faculty appointment or equivalent at academic universities, hospitals and research institutions; from those who are employees of small businesses, startup companies, non-profit organizations, or pharmaceutical companies committed to research in the area of maternal and infant health.

---

Josiah Macy Jr. Foundation

Deadline: September 20, 2024

Funding: up to $100,000 in total costs over the 18-month period

Purpose:
The Josiah Macy Jr. Foundation and Accreditation Council for Graduate Medical Education are partnering to present the Catalyst Awards for Transformation in Graduate Medical Education. The Catalyst Awards support projects that impact the clinical learning environment and improve the experience of residents and fellows in one of the three priority areas supported by the Josiah Macy Jr. Foundation:

• Promoting diversity, equity and belonging
• Increasing opportunities to learn in and from high-performing interprofessional teams
• Preparing future health professionals to navigate ethical dilemmas

Successful proposals will describe, implement and evaluate innovative strategies to equip learners with the tools, skills and strategies to flourish in the clinical learning environment. The first two completed cycles have already demonstrated the potential of these awards to make positive changes within their specific learning environments as well as to provide important models that can be utilized by other programs and institutions.

Eligibility:
Applications may be submitted by any resident, fellow and faculty member involved with graduate medical education.

---

Alzheimer's Drug Discovery Foundation

Deadline:
September 30, 2024, 5 p.m. ET, letter of intent
If invited, full proposal due December 9, 2024

Funding:  Up to $5,000,000

Description
The Drug Development RFP supports investigational new drug-enabling studies (or the international equivalent) and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease and related dementias. Both disease-modifying and symptomatic agents will be considered.

This funding opportunity prioritizes diverse drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia. For this reason, amyloid targeted approaches and cholinesterase inhibitor proposals will not be considered for this RFP.

Eligibility
Funding is open to researchers and clinicians worldwide at:

• Academic medical centers and universities or nonprofits. Industry partnerships are strongly encouraged.
• Biotechnology companies. Existing companies and new startups are both eligible.
• NOTE: Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones (see Our Research Strategy for more information).

Whitehall Foundation

Deadline: October 1, 2024, Letter of Intent
If invited, full application due February 15, 2025

Funding:
The maximum budget is $100,000 per year for the two- and three-year research grants.

Purpose:
Research grants are available to established scientists of all ages working at accredited institutions in the United States. Applications will be judged on the scientific merit and the innovative aspects of the proposal as well as on the competence of the applicant. Research grants of up to three years will be provided. A renewal grant with a maximum of two years is possible, but it will be awarded on a competitive basis. Research grants will not be awarded to investigators who have already received, or expect to receive, substantial support from other sources, even if it is for an unrelated purpose.

Eligibility:
The applicant must meet all of the following eligibility requirements in order to participate in the application process:

• Appropriate title – must be an assistant professor (or higher). If the institution does not use this title, a letter from the department chair confirming the applicant's eligibility is required.
• Status – must hold principal iInvestigator status.
• Independent – must be considered an "independent investigator" with their own dedicated lab space or with lab space independent of another investigator.
• The Foundation does not fund investigators who have substantial (approximately $200,000 per year) extramural funding. The Foundation uses the following formula to determine the PI's total extramural funding: Total direct per year plus total indirect per year less any PI salary taken from these grants. If this amount is greater than approximately $200,000 the PI would not be eligible for Whitehall Foundation funding. Startup funds and internal funding are not included in the calculation.

---

American Heart Association
2025 Established Investigator Award

Deadline: October 2, 2024, 3 p.m. CT, Letter of Intent

Amount:
$110,000 per year over five years, including 10% indirect costs (Indirect costs are not to exceed $11,000 per year)

Purpose
To support established investigators at the associate professor level, who are in a rapid growth phase of their career, have established records of accomplishments and continue to show extraordinary promise.

The investigator’s career is expected to clearly benefit from the EIA award.

Candidates will have a demonstrated commitment to cardiovascular or cerebrovascular science disciplines that support the AHA’s mission to be a relentless force for a world of longer, healthier lives, as indicated by funding and publication history and scientific accomplishments.

Candidates should propose an innovative/novel research direction that challenges existing paradigms and employs novel concepts, approaches or technologies.

Eligibility:
At the time of application, must have:

• MD, PhD, DO, DVM or equivalent doctoral degree
• Full-time faculty/staff scientist position or equivalent
• At the time of award activation must have an appointment at the ASSOCIATE PROFESSOR LEVEL or equivalent (including, but not limited to, research associate professor, research scientist, staff scientist, etc.) and be no more than 15 years since first faculty appointment.
• History and current evidence of substantial extramural funding

---

American Heart Association
2025 Collaborative Sciences Award

Deadline: October 3, 2024, 3 p.m. CT: Pre-Proposal
If invited, full proposal due January 9, 2025

Amount: $1,000,000 over three years:

• The award may be used for salary and fringe benefits of the co-principal investigators, collaborating investigator(s) and other participants with faculty appointments, consistent with percent effort, and for project-related expenses such as salaries of technical personnel essential to the conduct of the project, supplies, equipment, computers/electronics, travel (including international travel), volunteer subject costs, data management and publication costs, etc.
• Indirect costs are limited to 10% of the annual award total.
• AHA does not require use of the NIH salary cap.

Purpose:

• To foster innovative, collaborative approaches to research projects that propose novel pairings of investigators from at least two broadly disparate disciplines. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of at least two co-principal investigators and their respective disciplines.
• The combination and integration of studies may be inclusive of basic, clinical, population, behavioral and/or translational research. Projects must include at least one co-PI from a field outside cardiovascular and cerebrovascular disease.
• This award is also intended to foster collaboration between established and early- or mid-career investigators.
• Applications by existing collaborators are permitted, provided that the proposal is for a new and novel idea or approach that has not been funded before.

Eligibility:
An application must be submitted jointly by at least two co-principal investigators, but no more than four.

All co-PIs must be AHA Professional Members at the time of pre-proposal submission.

• At least one co-PI must work in cardiovascular or cerebrovascular-related research.
• At least one co-PI must work in a divergent/disparate discipline (e.g., engineering, computer science, chemistry, mathematics, psychology, health law, etc.) and/or without prior focus in cardiovascular- or cerebrovascular-related research.
• At least one co-PI must be an early-career (assistant professor or equivalent) or mid-career (associate professor or equivalent) investigator.
• Co-PIs must each hold faculty/staff appointments.
• Co-PIs must be independent researchers (i.e., must meet their institutions’ eligibility to apply for independent awards). This award is not intended for individuals in research training or fellowship positions.
• Co-PIs may be from the same institution or from different institutions.
• Co-PIs must be from different disciplines and/or areas of expertise. For example: A collaboration between a clinician and a basic scientist or other collaboration that would not arise otherwise (organically).
• Examples of partnerships that have been funded:
• A materials scientist with no previous cardiovascular or cerebrovascular-related research collaborating with an interventional cardiac electrophysiologist
• A synthetic biologist collaborating with a cardiac biologist
• A chemist specializing in RNA molecular biology collaborating with a practicing neonatologist with research in cell signaling, hemostasis and thrombosis
• A kidney disease/ciliopathy researcher collaborating with a clinical researcher in genetic causes of bicuspid aortic valve disease and a basic science researcher also studying genetic valvular diseases
• The applicants should adequately convey that they are of equal stature in the project.
• If more than three co-PIs are proposed, the applicants should provide clear evidence that they are equal co-PIs. If this will not be the case, then the applicants should classify additional personnel as collaborating investigators or consultants.
• Each co-PI must hold an MD, PhD, DO, DDS, DVM or equivalent post-baccalaureate terminal (highest-level) degree in their discipline.
• One of the co-PIs’ institutions must be designated as the institution of record, agreeing to sponsor the application and accept award payments and ensuring that annual progress reports and expenditure reports are submitted to AHA.

---

G. Harold and Leila Y. Mathers Foundation – Limited Submission

Deadline:
October 4, 2024, Letter of Intent
If invited, full proposal due December 6, 2024

Funding:
Beginning in 2024 fall cycle: The maximum allowable budget is $700,000 (inclusive of 10% maximum IDC for direct costs). 

Purpose:

• The Foundation primarily supports basic science, ideally with potential translational applications.
• Examples of current research areas we support include immunology, microbiome, structural biology, cellular physiology, cancer biology, genetics, genomics, microbiology and infectious diseases, stem cell biology and neuroscience.
• Research areas we will not consider for support include COVID-19-related research projects (aims or sub-aims),plant biology research, oceanography, space exploration and global warming-related research. In addition, medical imaging technology-related projects and/or electrical engineering technology development projects will not be considered for support.
• The Foundation does not support research conducted in human subjects and will not fund requests for clinical trials or drug discovery. The Foundation will not support research projects that we consider pre-clinical drug development.
• Renewal applications for the same or related research will not be accorded priority consideration. It is strongly advised that any reapplication for grant renewal consider a new direction based on prior research or emphasize some new potential translational aspects and not merely an extension of previously funded research.
• Requests for funding previously federally supported research and/or applications pending federal approval will not be accorded priority consideration.
• In general, the Mathers Foundation reviewers look for innovative, novel proposals that have scientific merit with an established published proof of concept, and which may not be fundable at the federal level. 
• Currently, we do not offer advice about proposed project ideas or screen LOIs before they are submitted. The Mathers Board believes that the information on the website provides sufficient guidance for a wide variety of research projects that could be considered for support.

Eligibility

• Collaborative research projects with other U.S. based organizations are acceptable. Research collaborations between U.S.-based organizations and organizations based outside the U.S. are not encouraged and will be given lower priority.
• Funds can only be awarded to U.S.-based research institutions that directly support investigators; no grants will be made to third party organizations.

---

American Cancer Society

Deadline: October 15, 2024

Funding: Two years with $135,000 per year direct costs, plus 10% allowable indirect costs

Purpose: To fund exploratory research to develop research methodologies, establish feasibility or pilot test high-risk/high-reward research across the research continuum.

Eligibility: Independent investigators at any career stage.

---

American Cancer Society
Research Scholar Grants

Deadline: October 15, 2024

Funding:
Research Scholar Grants are funded up to $215,000 per year (direct costs), plus 10% allowable indirect costs, with a project period up to four years.

Purpose:
Research Scholar Grants (RSG) provide support for independent, self-directed researchers. Applicants' institutions must provide space and other resources customary for independent investigators. Grant proposals are investigator-initiated and may pursue questions across the cancer research continuum, as long as they fit within an American Cancer Society (ACS) priority research area. These grants typically contribute to the cost of salaries, consumable supplies and other miscellaneous items required in the research. 

Eligibility

• Work at a U.S. academic institution or eligible nonprofit.
• Were first appointed as independent, full-time faculty less than 10 years ago. (To ask about eligibility extensions due to personal or professional leave, send your questions to grant.eligibility@cancer.org at least six weeks before the application deadline.)
• Are the PI on no more than 1 R01 or R01-equivalent grant at the time of application.

---

American Cancer Society
Postdoctoral Fellowships

Deadline: October 15, 2024

Funding:

• Awards are for up to three years with recently increased progressive stipends of $66,000, $68,000 and $70,000 a year.
• Fellowship allowances: Fellows will receive $4,000 a year to help defray costs such as health insurance, workshop costs and expenses associated with presenting at a domestic scientific meeting.
• In the last year, an additional $1,500 is added to the fellowship allowance for PFs to attend either the ACS Postdoctoral Fellows Symposium or a domestic scientific meeting.

Purpose:
Postdoctoral Fellowships support new investigators in research training programs to position them for independent careers in cancer research. As part of their evaluation, peer reviewers consider how well the fellowship will broaden the applicant’s research training and experience.

Eligibility

Eligible applicants:

• Are a U.S. citizen or a non-citizen holding an appropriate visa when they submit their application.
• Have had their doctoral degree for LESS than four years; time spent in clinical-only training is not counted. To ask about exemptions due to personal or professional leave, at least six weeks before the application deadline, send your questions to grant.eligibility@cancer.org
• Do not have a faculty appointment (e.g., instructor, research assistant professor)
• Applicants should review the American Cancer Society’s Grant Policies and the Instructions about the fellowship.

McKnight Foundation

Deadline: November 4, 2024, Letter of Intent
If invited, full proposals due mid April 2025

Amount: $100,000 per year for three years

Purpose:
The first step is to submit a two-page letter of intent describing how the McKnight award would permit new approaches and accomplishments toward the development of translational research. The letter should address the following questions:

• What clinical problem are you addressing?
• What are your specific aims?
• How will the knowledge and experience you have gained in basic research be applied to improving the understanding of a brain disorder or disease?
• How are you fostering an inclusive and equitable lab environment?

The letter should clearly describe how the proposed research will uncover mechanisms of brain injury or diseases and how it will translate to diagnosis, prevention, treatment or cure.

The letter of intent should include the email addresses of the principal investigators and a title for the project.

Eligibility:
A candidate for a McKnight Neurobiology of Brain Disorders Award must work as an independent investigator at a not-for-profit research institution in the United States, and must hold a faculty position at the rank of assistant professor or higher. Those holding other titles such as research professor, adjunct professor, professor research track, visiting professor or instructor are not eligible. If the host institution does not use professorial titles, a letter from a senior institutional official (e.g., dean or director of research) must confirm that the applicant has their own dedicated institutional resources, laboratory space and/or facilities.

Cardiovascular Medical Research and Education Fund
Improving the Treatment of Pulmonary Diseases

Deadline: Rolling

Funding:
Preference will be given to proposals that have budgets below $100,000 and timelines less than two years.

Purpose:
The CMREF mission of the fund is to support educational activities that will enhance the knowledge of pulmonary hypertension and research projects that may help uncover the causes and pathogenesis of idiopathic pulmonary arterial hypertension (IPAH) in pursuit of the ultimate goal of its treatment and cure. The CMREF does not have a formal application process to fund clinical research or educational projects but is always interested in potentially providing full or partial support to initiatives that are novel, innovative or address the spectrum of unmet medical needs related to pulmonary vascular diseases.

Interested parties should submit a letter of intent (maximum of two pages) that describes the project sufficiently so that the Research Advisory Committee can understand the proposed goals and methods. In addition, the letter should mention the length of time of the project and an estimated overall budget.

How to Apply:
To submit your letter, please use the form on this page. Please be sure to fill out all fields and upload your letter before submitting. You can also email your letter directly to Patt Wolfe (executive director) at patt.wolfe@ipahresearch.org.

After you submit your letter, the CMREF will respond within four weeks to inform you if a full application will be requested.

---

American Federation for Aging Research
Medical Student Training in Aging Research (MSTAR) Program

Deadline:
Interested students should be in touch directly with the National Training Centers to for the program deadline and application materials.

Funding:
The stipend level is approximately $1,980 per month; actual amounts will vary based on the specific appointment period of individual students. Award period: Eight to 12 weeks.

Purpose:
The MSTAR Program provides medical students with an enriching experience in aging-related research and geriatrics, with the mentorship of top experts in the field. This program introduces students to research and academic experiences early in their training that they might not otherwise have during medical school. Positive experiences in the MSTAR program have led many physicians-in-training to pursue academic careers in aging, ranging from basic science to clinical research to health services research. They have joined the growing cadre of physicians and scientists whose specialized knowledge and skills are in great demand as our population ages.

Students participate in an eight- to twelve-week (or two- to three-month, depending on the training site) structured research, clinical and didactic program in geriatrics, appropriate to their level of training and interests. Research projects are offered in basic, translational, clinical or health services research relevant to older people. Most scholars will do their training and research during the summer months. They will also be invited to submit an abstract to present a poster at the annual meeting of the American Geriatrics Society.

Eligibility

• Any allopathic or osteopathic medical student in good standing, who will have successfully completed one year of medical school at a U.S. institution by June 2024. Evidence of good standing must be provided by the medical school registrar or dean when the student is notified of receiving the award.
• Applicants must be citizens or non-citizen nationals of the United States, or must have been lawfully admitted for permanent residence (i.e., in possession of a currently valid Alien Registration Receipt Card I-551, or some other legal verification of such status). Individuals on temporary or student visas are not eligible. Due to NIA restrictions, individuals holding PhD, MD, DVM or equivalent doctoral degrees in the health sciences are not eligible to apply to do the MSTAR Program.
• Additionally, applicants receiving a stipend or salary support from a federal source are not eligible for this program. Applicants may not hold another award or participate in another program concurrently with the MSTAR program, and must participate in the program full-time for a minimum of eight weeks and a maximum of 12 weeks.

---

Infectious Diseases Society of America
Grants for Emerging Researchers/Clinicians Mentorship Program

Career Stage: Medical Students

Amount: Not specified

Deadline: Ongoing

Description
The G.E.R.M. Program was developed to provide grants to medical students to support a longitudinal, mentored clinical learning and/or research project for up to a year on infectious diseases-related topics, including HIV, under the mentorship of an IDSA or HIVMA member. This program replaced the IDSA Medical Scholars and HIVMA Medical Students Programs.

Eligibility

• Graduate students
• Applicants must be medical students (first-, second- or third-year and those in combined degree programs, including MD/MPH and MD/PhD) from an accredited allopathic or osteopathic medical school in the U.S.